Chromadex Corp Stock
Chromadex Corp Stock
Chromadex Corp shows a slight decrease today, losing -€0.020 (-0.500%) compared to yesterday.
Our community identified positive and negative aspects for Chromadex Corp stock for the coming years. 0 users see the criterium "EBIT Margin" as a plus for the Chromadex Corp stock. On the other hand our users think that "EBIT Margin" could be a problem in the future.
Pros and Cons of Chromadex Corp in the next few years
Pros
?
M***** P*******
?
C******** o* t** e**********
?
S********** s********
Cons
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Chromadex Corp vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Chromadex Corp | -0.500% | -2.439% | 4.167% | -37.500% | -27.273% | 222.581% | -37.984% |
| Intellia Therapeutics Inc | -14.260% | -8.346% | 4.582% | 62.072% | 49.116% | -64.802% | -82.020% |
| Cardio3 Biosciences S.A. | -0.720% | 0.365% | -4.844% | -40.605% | 103.704% | -54.620% | -94.841% |
| Polynovo Ltd | 0.000% | 0.877% | 12.745% | -6.504% | -15.441% | -43.627% | -71.250% |
Comments
ChromaDex Co. (NASDAQ: CDXC) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
Show more
Ratings data for CDXC provided by MarketBeat
ChromaDex Co. (NASDAQ: CDXC) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
Show more
Ratings data for CDXC provided by MarketBeat
ChromaDex Co. (NASDAQ: CDXC) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
Show more
Ratings data for CDXC provided by MarketBeat